Verywell Health on MSN
Experimental treatments for type 2 diabetes
Medically reviewed by Jane Kim, MD Key Takeaways Mounjaro is the first dual GIP and GLP-1 agonist medication approved for ...
Across all income levels, bariatric surgery resulted in better diabetes control than GLP-1s or similar medications, a study ...
Stem cell therapy is an emerging treatment for type 2 diabetes. Although it’s not yet FDA-approved in the United States, it is a rapidly expanding and promising field of research. Stem cells are ...
WILMINGTON, Del.--(BUSINESS WIRE)--AstraZeneca’s FARXIGA ® (dapagliflozin) has been approved by the US Food and Drug Administration (FDA) to improve glycemic control in pediatric patients with type-2 ...
Starting a new type 2 diabetes treatment can feel overwhelming, but asking the right questions helps you manage it better.
Forbes contributors publish independent expert analyses and insights. Juergen Eckhardt leads Bayer’s impact investment unit, Leaps by Bayer. As a venture investor in healthcare, I am privileged to ...
Millions of people with type 2 diabetes could receive better treatment thanks to a new, simple low-cost tool, according to groundbreaking research announced today at the Diabetes UK Professional ...
Type 2 diabetes can decrease saliva production and increase glucose levels in saliva. This may lead to plaque and tartar buildup on teeth and gums, increasing the chances of developing gum disease.
Onlymyhealth on MSN
Study shows Nordic diet may treat type-2 diabetes and fatty liver – expert decodes
You must have heard about the Mediterranean diet. It emphasises on plant-based foods, particularly unprocessed cereals, ...
By combining genomic and plasma proteomic data from a Ugandan cohort, the researchers mapped nearly 400 genetic regions that ...
Over the past few decades, doctors have noticed a sharp increase in type 2 diabetes among Black children and teenagers. Since type 2 diabetes is showing up earlier in life, it is leading to more ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results